Farnesoid X receptor regulates vasoreactivity via Angiotensin II type 2 receptor and the kallikrein-kinin system in vascular endothelial cells

The kinin system in hypertensive pathophysiology

(2012) Jagdish N. Sharma   INFLAMMOPHARMACOLOGY

A Role of the Bile Salt Receptor FXR in Atherosclerosis

(2010) Jurre Hageman et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Farnesoid X Receptor Activation Prevents the Development of Vascular Calcification in ApoE −/− Mice With Chronic Kidney Disease

(2010) Shinobu Miyazaki-Anzai et al.   CIRCULATION RESEARCH

A synthetic farnesoid X receptor (FXR) agonist promotes cholesterol lowering in models of dyslipidemia

(2009) Mark J. Evans et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Chronic stimulation of farnesoid X receptor impairs nitric oxide sensitivity of vascular smooth muscle

(2008) Taiki Kida et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Antiatherosclerotic effect of farnesoid X receptor

(2008) Andrea Mencarelli et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY